CFGS
BIOL

Concourse Financial Group Securities’s Biolase, Inc. BIOL Stock Holding History

Concourse Financial Group Securities’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5
Closed -$4.61K – 2483
2021
Q4 		$5K Sell
5
-1
-17% -$1.26K ﹤0.01% 2067
2021
Q3 		$9K Hold
6
– – ﹤0.01% 1934
2021
Q2 		$11K Hold
6
– – ﹤0.01% 1858
2021
Q1 		$14K Hold
6
– – ﹤0.01% 1681
2020
Q4 		$7K Hold
6
– – ﹤0.01% 1814
2020
Q3 		$4K Hold
6
– – ﹤0.01% 1900
2020
Q2 		$8K Hold
6
– – ﹤0.01% 1567
2020
Q1 		$6K Buy
+6
New +$9.32K ﹤0.01% 1626

Other funds holding BIOL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return

Concourse Financial Group Securities's BIOL Position: Q1 2022 in Review

Concourse Financial Group Securities sold out of Biolase, Inc. (BIOL) in Q1 2022, closing a stake of 5 shares — an estimated $4.61K sold.

Concourse Financial Group Securities first reported a position in BIOL in Q1 2020 and held it in 8 quarters. The position peaked at $14K in Q1 2021. 28 funds tracked by Wall St. Rank hold BIOL as of Q1 2022.

  • Concourse Financial Group Securities reported no remaining Biolase, Inc. position as of Q1 2022 after selling out during the quarter.
  • Concourse Financial Group Securities sold 5 Biolase, Inc. shares in Q1 2022, an estimated $4.61K.
  • Concourse Financial Group Securities first reported a position in Biolase, Inc. in Q1 2020 and held it in 8 quarters.
  • Concourse Financial Group Securities's Biolase, Inc. position peaked at $14K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Biolase, Inc. as of Q1 2022.

Based on Concourse Financial Group Securities's 13F filing for Q1 2022, filed 9 May 2022.